Veronica Sanchez Bulis, VP, Corporate Controller at Lyell Immunopharma, Inc. (LYEL), sold 2,072 shares at $32.32 ($74K) on 2025-12-30, disclosed to the SEC on 2026-01-06.
Open-market sale of $74k LYEL by VP, Corporate Controller. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.67 | 1,136 | $44K | 59.2% |
| 2 | $32.32 | 936 | $30K | 40.8% |
| Total | $35.80 avg | 2,072 | $74K | 100% |
| Filing → |
| LYEL | SELL | 2026-02-11 | $6K | — | Filing → |
| LYEL | SELL | 2025-11-12 | $4K | — | Filing → |